UNDA 34 (Seroyal USA)


Welcome to the PulseAid listing for the UNDA 34 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Humulus lupulus, Juniperus communis, Equisetum arvense, Hydrastis canadensis, Syzygium jambolanum, Aurum metallicum
SUBSTANCE NAME: HOPS; JUNIPERUS COMMUNIS WHOLE; EQUISETUM ARVENSE BRANCH; GOLDENSEAL; SYZYGIUM CUMINI SEED; GOLD
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-06-10
END MARKETING DATE: 0000-00-00


UNDA 34 HUMAN OTC DRUG Details:

Item DescriptionUNDA 34 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4; 4; 4; 4; 12([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2015-06-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1133_5aa7289a-9987-47be-e053-2991aa0ad7b0
PRODUCT NDC: 62106-1133
APPLICATION NUMBER:

Other HOPS; JUNIPERUS COMMUNIS WHOLE; EQUISETUM ARVENSE BRANCH; GOLDENSEAL; SYZYGIUM CUMINI SEED; GOLD Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUNDA 34